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Hyper-immunoglobulin E syndromes (HIES) including compound primary immunodeﬁciency and nonimmunological
abnormalities are characterized by extremely high serum IgE levels, eosinophilia, eczema, susceptibility to infections, distinctive
facial appearance, retention of deciduous teeth, cyst-forming pneumonias, and skeletal abnormalities. Itis reported that some
cases of familial HIES are relative to autosomal dominant or recessive inheritance, but most cases are sporadic, and result from
mutations in the human signal transducer and activator of transcription 3 (STAT3) gene. In this paper, we ﬁrstly report a young
man diagnosed of Hyper-IgE syndrome with STAT3 mutation in Mainland China, and investigate the autosomal dominant trait
of his family members.
1.Introduction
The hyper-IgE syndromes (HIES) are rare primary immune
deﬁciencies characterized by elevated serum IgE, dermatitis,
and recurrent skin and lung infections. There are two
forms of HIES: a dominant form caused by mutations in
STAT3, and a recessive form, for which a genetic cause
is unclear. These two diﬀerent syndromes have distinct
presentations, courses, and outcomes and share very little in
terms of pathogenesis other than the IgE elevation. In this
paper, we ﬁrstly report a young man diagnosed of Hyper-
IgE syndrome with STAT3 mutation in Mainland China,
and investigate the autosomal dominant trait of his family
members.
Our patient, a 20-year-old man in mainland China,
was suﬀering from eczema, lung cyst, skeletal and dental
abnormalities, and so forth, which are the characteristics of
type 1 HIES. He has extremely high serum IgE level is 200
times than that of normal person. Then, we sequenced the
STAT3 gene by complementary DNA (cDNA) and genomic
DNA, and we found a mutation locus, in which his parents
and sister are normal.
2. Patient andDiagnosis
A 20-year-old man was found to presented with over ten-
years history of cough with yellow-colored sputum and one
year history of bloody sputum. He also reported universal
boils on the face and limbs and recurrent pneumonias. In
1998, he received right upper lung cyst surgical therapy. His
medical history was signiﬁcant for eczema since newborn
period and recurrent pustular and eczematoid rashes on
the face and scalp in the childhood. Several primary teeth
arrachement surgeries were performed in 13 years old on
account of failure of the primary teeth to exfoliate.
On physical examination, the vital signs were normal,
clubbed ﬁngers and toes; the characteristic facial appearance
was noted with broad nose, deep-set eyes with a promi-
nent forehead (Figure 1(a)), and a rough facial skin with
exaggerated pore size. Flat chest, scattered rash scars were
showed on the chest skin. Bilateral ﬁne crackles were audible
in the lower lung, decreased breath sounds at the right
base, and scattered expiratory wheeze bilaterally. Abdominal
examination revealed moderate left middle abdominal ten-
derness.2 Clinical and Developmental Immunology
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Figure 1: Symptoms. (a) The patient with broad nose, deep-set-eyes, a prominent forehead, and a rough facial skin with exaggerated pore
size. (b) Multiple cysts in the left upper abdomen.
Theleukocytecountwas11,350cells/L(62%neutrophils,
19% lymphocytes, and 9% eosinophils). The hemoglobin
concentration was 104g/L, the red blood cell count 3.82 ×
1012/L, and the platelets count was 354 × 109/L. The
erythrocyte sedimentation rate (ESR) was 87mm/h. The
C-reactive protein (CRP) was 7.15mg/dL. The ﬁndings of
further laboratory workup included the following: serum
IgA, 135.0mg/dL (reference range, 70 to 400mg/dL); serum
IgG, 2,560.0mg/dL (reference range, 700 to 1600mg/dL);
and serum IgE, 37,700.0IU/mL (reference range, 0 to
100IU/mL). IgM concentrations (subclasses included) were
within the normal range. CD4/CD8 count was normal.
The ﬁndings of an enzymelinked immunosorbent assay for
HIV antibody and an antineutrophil antibody screen were
negative.
A chest CT scan showed extensive consolidation and
cystic changes in the right lung and patchy inﬁltration and
cystic changes in the left lower lung. An abdominal CT scan
revealed a big lower density mass measured 10.6cm×9.5cm
with multiple cysts in the left upper abdomen (Figure 1(b)).
Bronchoscope examination found multimucous sputum in
the tracheal and right and left bronchus. Percutaneous
abdominal mass puncture and drainage guided by ultra-
sonography were performed, and laboratory examination of
drainage liquid reported purulent ﬂuid with a great amount
of leukocytes. Cultivation of bacteria both in abdominal
abscess and bronchial alveolar lavage ﬂuid (BALF) revealed
staphylococcus aureus (Methicillin sensitive staphylococcus
aureus, MSSA).
Basedontheseﬁndings,wemadethediagnosisofHyper-
IgE syndrome (HIES). According to these characteristics, we
conﬁrmed it the type 1 HIES. (This study was approved by
the patient and informed consent was obtained from the
families).
3.MaterialandMethod
3.1. Mutational Analysis. EDTA blood was obtained and
genomic DNA was isolated by using standard methods.
All 24 exons and exon/intron boundaries were separately
ampliﬁed by PCR. (The primers were designed according
to GenBank NG 007370, the mutation in Exon 15 was
ampliﬁed with 15F-5 -GATGGAGTTTTGCTGTGCTG-3 
and 15R-5 -AGATGGGATGCCAAGGATTT-3 ).
3.2. Total RNA Extraction and cDNA Preparation. Total RNA
was prepared from leucocyte of whole blood samples of the
patient and his families using the QIAZOL Lysis Reagent
(RNeasy Lipid Tissue) isolation method according to the
manufacturer’s protocols (Qiagen, Valencia, CA, USA). Total
RNA was isolated from by an RNeasy mini kit (Qiagen,
Valencia, CA, USA) according to the manufacturers’ instruc-
tions. About 1μg RNA was reverse transcribed into single-
strand cDNA using oligo(dT) 18-mer primers and M-MLV
Reverse Transcriptase (Invitrogen, Karlsruhe, Germany).
3.3. Quantitative Real-Time RT-PCR. Real-time RT-PCR
was performed on a ﬂuorescence thermal cycler (ABI Prism
7900HT Sequence Detection System, Applied Biosystems).
A standard two-step procedure was applied. RNAs were
reverse transcribed into single strand cDNAs using oligo
dT primers and M-MLV reverse transcriptase (Invitrogen,
Karlsruhe, Germany). Real-time RT-PCR was performed in
15-μL reaction mixtures consisting of cDNA, 0.5μMs p e c i ﬁ c
primer sets for each target gene, and SYBR Green PCR
Master Mix (Applied Biosystems, UK). Conditions were:
50◦Cf o r2m i n u t e s ,9 5 ◦Cf o r1 0m i n u t e s ,f o l l o w e db y
40 repetitive cycles of 95◦C for 15 seconds, and 60◦Cf o r
1 minute. Details of melting curve analysis and relativeClinical and Developmental Immunology 3
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Figure 2: Sequencing results of STAT3 cDNA. (a) Heterozygous mutation in STAT3 genomic sequence of the patient. (b) Schematic of
STAT3 amino acid structure and the identiﬁed mutation, H437P (1310A → C) in the DNA binding domain. (c) Pedigree of this family
aﬀected by the Hyper-IgE syndrome, the mutation was de novo, not inheritance.
standard curve generation were described in Supplemental
Materials and Methods. β-actin was used as internal controls
to normalize for initial RNA input and this gene was
found to display remarkably stable expression levels across
experimental treatments. (The primers of stat3 gene for RT-
PCR were F: 5 -CAGTCCGTGGAACCATACACA-3 ,R :5  -
GACCAGTGGAGACACCAGGATA-3 ; the primers of β-
actin for RT-PCR were F: 5 -AAGATCATTGCTCCTCCT-
GAGC-3 ,R :5  -TCCTGCTTGCTGATCCACATC-3 ).
3.4. Analysis of Allelic Expression of STAT3 Gene. Pyrose-
quencing technology on the PyroMark ID instrument was
used to analyze allelic expression of stat3 gene at the
mutational locus. Amplifying the dsDNA by PCR with one
biotinylated primer (R-pyro: 5 -CACGACGTTGTAAAA-
CGACGGAGTGGGTCTCT-3 ) and one unlabelled primer
(F-pyro: 5 -CCGAGCCAATTGTGATGC-3 ); immobilizing
the DNA samples, typically 2pmol PCR product, 109bp
in length (CCGAGCCAATTGTGATGCTTCCCTGATTGT-
GACTGAGGAGCTG C[A/C]CCTGATCACCTTTGAG-
ACCGAGGTGTATCACCAAGGCCTCAAGATTGACCTA-
GAGACCCACTCC), to Streptavidin Sepharose beads; sepa-
rating the DNA strands; dispensing the ssDNA samples into
the wells of the PSQ 96 Plate Low; annealing the samples to a
sequencing primer (Seq-pyro: 5 -TGACTGAGGAGCTGC-
3 ) were carried out.
4. Results
4.1. The Identiﬁed Mutation in the STAT3 Gene. Several
previous studies have showed mutations in the STAT3 gene
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Figure 3: Relative STAT3 mRNA expression levels in the family.
The expression of the patient is twice times lower than his families
control.
on chromosome 17q21 as major causes of AD and sporadic
HIES [1, 2]. We thus sequenced the regulatory region, the
coding exons, and the intron-exon junctions of the STAT3
geneinthepatientandhisfamilies.Aheterozygousmutation
H437P (1310A → C) occurred only in the patient who
had extremely high IgE level. This mutation seemed to be
de novo since none of the parents and the sibling of the
patients carried this mutation, (Figure 2) with Mildly to
moderately elevated IgE levels for his mother (162IU/mL)
and his younger sister (887IU/mL).4 Clinical and Developmental Immunology
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Figure 4: Pyrosequencing results (a) 38.9% C and 61.1% A at the mutational point of the patient. (b)–(d) 100.0% A and 0.0% C at the
corresponding point of his parents and sister.
4.2. The Gene Express Analysis of STAT3 by Real-Time PCR.
The mRNA expression of STAT3 gene in the leucocyte from
whole blood samples of the patient and his families control
was examined by RT-PCR, using a pair of speciﬁc primers
amplifying a 111-bp amplicon of this gene. The house-
keeping gene β-actin was used as an internal control for
normalization. A relatively reduction level of expression of
STAT3 gene can be observed in the patient (Figure 3).
4.3. The Allele Expression Quantiﬁed by cDNA Pyro-Sequence.
To study this mutated allele expression more directly, we
quantiﬁed the relative expression of alleles in leucocyte from
whole blood samples of the patient and his families control
using the 1310A → C SNPs located in the Exon 15 of
STAT3 gene. cDNA sequences from patient samples revealed
expression of both alleles (38.9% C and 61.1% A through the
exactly calculation) indicating the mutated transcription of
STAT3 gene present in the patient. The association between
the expression levels implies that the 1310A → CS N P si st h e
causative mutation for this dominant case (Figure 4).
5. Discussion
In 1966, the syndrome was ﬁrst described as “Job’s syn-
drome” by Davis et al. in two girls suﬀering from recurrent
“cold” staphylococcal abscesses, pneumonia, and neonatal-
onset eczematoil rash, referring to the Biblical Job, who
w a s“ s m o t ew i t hs o r eb o i l s ”[ 3]. Then the disease was
reported as hyper-IgE syndrome by Buckley et al. in 1972
because they found that these symptoms were associated
with exceptionally high serum concentrations of IgE [4].
HIES is a rare immunodeﬁciency syndrome of which
the exact pathogenesis is still unknown. There is no speciﬁc
clinical and laboratory test for conﬁrming. Several symp-
toms such as elevated IgE levels and eosinophilia might
also be found in other immunodeﬁciency syndromes [5].
Therefore, we must synthetically analyze the medical history,
appearance and skin characteristics, visceral abnormalities,
and necessary laboratory study ﬁndings including cytokines
and immunoglobulins levels. Our patient’s pathogenesis was
not working out until all the abovementioned aspects were
examined.Andallthesymptomsindicatedthatheisapatient
with hyper-IgE syndrome.
The diagnosis of HIES is diﬃcult to be conﬁrmed in
that both immunologic and somatic features need to be
identiﬁed prior to genetic testing. There are two forms of
HIES [6]. They have diﬀerent pathogenesis, processes, and
outcomes,and the only commonground is the IgE elevation,
with values reaching >2000IU (normal < 200IU) [7]. The
type 1 HIES, a dominant form caused by hypomorphic
mutations in STAT3, is a disease of multiorgan dysfunction.
Besides eczema and recurrent staphylococcal infections in
skin and lung, these patients suﬀer from abnormalities in
vessels, connective tissue, and skeleton [8]. STAT3 (signal
transducer and activator of transcription 3) is located on
human chromosome 17q21, which was reported to contain
a disease locus for familial autosomal dominant (AD)-HIES
[7]. It is a transcription factor, which binds to the STAT3-
responsive elements in the promoters of various genes and
plays a critical role in responses to many cytokines, in
which, IL-17 produced by TH17 cell is protective in the
host defence against extracellular bacteria [9], and IL-22
stimulatescellsintheskinandrespiratorysystemstoproduce
β-defensins through STAT3 activation [10]. Therefore, the
HIES aetiology might be directly and indirectly linked to
STAT3. In other words, a human deﬁciency in STAT3 is
a major cause of sporadic and familial HIES. The type
2 HIES is autosomal recessive (AR) syndrome [11]. The
patients with type 2 HIES did not show any skeletal and
dental abnormalities, and had no pulmonary cyst, but most
of them suﬀered from viral infections such as chronic
refractorymolluscumcontagiosumandherpessimplex virus
infections, which were not identiﬁed in type 1 HIES. The
genetic origin for a subpopulation of type 2 HIES is a null
mutation of tyrosine kinase 2 (Tyk2) [12].Clinical and Developmental Immunology 5
For the past few years, the research in the etiology
of HIES has got some achievements, especially with the
development of molecular biology. But it is not completely
clear to us. Until now, it is generally believed that STAT3
mutations act in a dominant negative manner to cause of
autosomal dominant HIES [13]. And Tyk2 deﬁciency acts
in a recessive manner to cause one of the cases of AR-
HIES,althoughothergenomiclocimayalsobeinvolved[14].
Most STAT3 mutations are restricted to the DNA-binding
or SH2 domains [15], and might concern the protein level,
phosphorylation, and nuclear localization. In our research,
we found a heterozygous mutation in the DNA-binding
region of STAT3 gene, it could be one of the essential causes
of the disease. Furthermore, may be his lower STAT3 protein
expression level is a result of the mutation. However, its
concrete eﬀect still remains to be studied, for instance, when
the mutation happens, how the STAT3 protein structure
changes, and how the underlying mechanisms and passages
make mistakes. They all need us to explore deeply.
6. Conclusion
These new and evolving genetic and immunologic under-
standings probably eventually lead to more eﬀective disease-
speciﬁc treatment for patients, including stem cell transplan-
tations and gene-targeted therapies.
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